Bookmarks
Welsh Neuroscience Research Tissue Bank (WNRTB)
Population Size
3,431
People
Years
2006
Associated BioSamples
Serum
Plasma
...see more
Geographic coverage
Wales
UK
Lead time
Variable
Summary
The purpose of the WNRTB is to serve as a repository of biological samples donated by people across the UK for use in studies advancing the understanding of, and care for, neurological diseases. Samples are obtained from healthy volunteers and from patients undergoing treatment at UK hospitals or locally to clinical or research groups. Research will be undertaken within Cardiff University laboratories, or other registered research institutes performing work on neurological diseases.
Documentation
The Welsh Neuroscience Research Tissue Bank is a collection of human (mainly fluid) biological samples donated from more than 3000 patients undergoing neurological investigations or who have known neurological diagnoses, as well as from healthy volunteers. Donors are recruited locally in South Wales, and from across the UK. Participants must be over the age of 16 and give consent for DNA analysis to take place. The collection comprises samples (for example, but not limited to blood, serum, plasma, CSF, DNA, RNA) from disorders such as Multiple sclerosis, Epilepsy, MND, Idiopathic Intracranial hypertension, brain tumours, as well as healthy volunteers. To date more than 100,000 sample aliquots are available for neurological research. Samples are available for research into neurological disorders via an application process and governance panel review. The WNRTB is authorised by the Wales REC 3 to release samples to researchers following a review of the intended use of samples. Researchers receiving samples from the WNRTB are deemed to have ethics approval and are therefore NOT required to have specific approval from an NHS ethics committee for the use of these samples, as samples will be provided anonymously with only the minimum data set. The WNRTB infrastructure also acts as a guardian to several major clinical trials and specific research projects, each contributing to a large resource available to researchers.
Keywords
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
---|---|---|---|---|
Persons | Persons diagnosed with Multiple sclerosis or other neuroinflammatory demyelinating disorder (e.g. CIS, NMO, ADEM) | 2575 | persons diagnosed with MS, CIS, NMO | 21 Feb 2025 |
Events | Total number of sample aliquots available to research from pwMS. | 92184 | sample aliquot | 21 Feb 2025 |
Events | Total number of Serum aliquots (300ul) from pwMS | 38004 | sample aliquot | 21 Feb 2025 |
Events | Total number of Plasma aliquots (300ul) from pwMS | 45946 | sample aliquot | 21 Feb 2025 |
Events | Total number of DNA samples from pwMS | 3787 | sample aliquot | 21 Feb 2025 |
Events | Total number of CSF aliquots (300ul) from pwMS | 3988 | sample aliquot | 21 Feb 2025 |
Events | Total number of other sample aliquots from pwMS (e.g. whole blood, PBMC, Tears) | 463 | sample aliquot | 21 Feb 2025 |
Persons | Participants diagnosed with Epilepsy | 366 | persons diagnosed with Epilepsy | 21 Feb 2025 |
Events | Number of DNA samples from patients with Epilepsy | 327 | sample aliquot | 21 Feb 2025 |
Events | Number of plasma sample aliquots from patients with Epilepsy | 2216 | sample aliquot | 21 Feb 2025 |
Events | Number of serum sample aliquots from patients with Epilepsy | 1911 | sample aliquot | 21 Feb 2025 |
Persons | Participants diagnosed with Motor Neuron Disease (MND) | 76 | persons diagnosed with MND | 21 Feb 2025 |
Events | number of DNA samples from persons with MND | 67 | samples | 21 Feb 2025 |
Events | number of plasma sample aliquots from persons with MND | 94 | sample aliquots | 21 Feb 2025 |
Events | number of serum sample aliquots from persons with MND | 71 | sample aliquots | 21 Feb 2025 |
Persons | Total participants (all diagnoses) | 3431 | participant | 24 Feb 2025 |
Events | Number of serum aliquots available in bank (all diagnoses) | 43347 | sample aliquot | 24 Feb 2025 |
Events | Number of plasma aliquots available in bank (all diagnoses) | 52203 | sample aliquot | 24 Feb 2025 |
Events | Number of CSF sample aliquots available in bank (all diagnoses) | 7855 | sample aliquot | 24 Feb 2025 |
Events | Number ofDNA samples available in bank (all diagnoses) | 4557 | sample | 24 Feb 2025 |
Provenance
Structural Metadata
Details
20/02/2025
Coverage
01/09/2006
Accessibility
Data Access Request
Application for release of samples for research will be by written request, using a specific request form (contact WNRTB@cardiff.ac.uk). Applications will be assessed by the Tissue Bank Governance Committee. The committee will meet to consider applications as required, with a deadline for a decision of 6 weeks from receipt of original signed copy. Where members of the governance committee are involved in a particular application for use of tissue, those members will not be involved in the consideration of that application and will not be present when it is discussed. Where necessary, the committee will seek external review from appropriate senior investigators in the UK neurology research community before coming to a decision. This is stated on the application form and applicants have the option of excluding particular external assessors if they wish. Applicants wishing to request further samples will be required to complete the Tissue Re-application Form for access to materials from the Welsh Neuroscience Research Tissue Bank.
We also welcome applications for pilot projects. A pilot project is defined as one that requires 20 samples or fewer and that is likely to lead to larger funded projects on successful completion. A maximum of 20 x sample aliquots can be requested, free of charge, to test proof of principle or to generate preliminary data required for funding applications. Applications will be reviewed by at least one Director and/or the Tissue Bank manager to ensure sample availability. Applications will not be circulated in full to the governance panel. A limit of one application per project is in place, and additional applications for tissue will be subject to a full application. Any samples supplied are to be used in the approved project only and for the agreed duration. Any remaining samples must be destroyed at the end of the project. If the samples are needed for an extended duration, or for a purpose other than that described in the approved application, an amendment must be submitted to the Tissue Bank and approved prior to any non-approved activities taking place. We understand that pilot studies may result in further funding and project extension and ask the researchers to contact the Tissue Bank to discuss any extension requests they may have. Of note, any requests for very specialised samples or rare diagnoses where cohort numbers are likely to be low, will be asked to complete a full application.
A signed Material Transfer Agreement (MTA) must be in place prior to supply of any samples outside of Cardiff University. A signed Tissue Request Form (memorandum of understanding) will be required for all researchers, including Cardiff University.